Lifevantage Corp (LFVN): Share Repurchases
$2.04M
Year ended 2026-06-30
+35.5%
3-year compound annual growth
-29.7%
5-year compound annual growth
| Period ended | Share Repurchases | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $2.04M | -35.1% | 2026-08-27, From 2025-07-01 |
| 2025-06-30 | $3.15M | -51.1% | 2026-08-27, From 2024-07-01 |
| 2024-06-30 | $6.43M | +682.2% | 2025-09-04, From 2023-07-01 |
| 2023-06-30 | $822.0K | -90.7% | 2024-08-28, From 2022-07-01 |
| 2022-06-30 | $8.83M | -26.0% | 2023-08-28, From 2021-07-01 |
| 2021-06-30 | $11.93M | +120.8% | 2022-08-23, From 2020-07-01 |
| 2020-06-30 | $5.41M | +16.1% | 2022-08-23, From 2019-07-01 |
| 2019-06-30 | $4.66M | +210.3% | 2021-08-19, From 2018-07-01 |
| 2018-06-30 | $1.50M | n/a | 2020-08-18, From 2017-07-01 |
| 2017-06-30 | $0 | n/a | 2019-08-14, From 2016-07-01 |
| 2016-06-30 | $0 | -100.0% | 2018-08-15, From 2015-07-01 |
| 2015-06-30 | $9.85M | -78.7% | 2017-09-07, From 2014-07-01 |
| 2014-06-30 | $46.17M | +548.2% | 2016-12-12, From 2013-07-01 |
| 2013-06-30 | $7.12M | +629.8% | 2015-09-01, From 2012-07-01 |
| 2012-06-30 | $976.0K | n/a | 2014-09-10, From 2011-07-01 |
| 2011-06-30 | $0 | n/a | 2013-09-12, From 2010-07-01 |
Share Repurchases at similar companies
| Company | Year ended | Share Repurchases | Change YoY |
|---|---|---|---|
| Lifevantage Corp (LFVN) | 2026-06-30 | $2.04M | -35.1% |
| Cryoport, Inc. (CYRX) | 2025-12-31 | $10.01M | n/a |
| Anaptysbio, Inc (ANAB) | 2025-12-31 | $68.63M | n/m |
| Keros Therapeutics, Inc. (KROS) | 2025-12-31 | $375.00M | n/a |
| Arvinas, Inc. (ARVN) | 2025-12-31 | $91.90M | n/a |
| Ligand Pharmaceuticals Inc (LGND) | 2025-12-31 | $15.00M | n/a |
| Zymeworks Inc. (ZYME) | 2025-12-31 | $41.70M | +38.7% |
| Siga Technologies Inc (SIGA) | 2025-12-31 | $0 | n/a |
| Standard Biotools Inc. (LAB) | 2025-12-31 | $0 | -100.0% |
Compare LFVN, CYRX, ANAB, KROS side by side · Screen every company in Pharmaceutical Preparations ↗